Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Anti-Racism, Healthcare, and Health Policy: How far can we go?, 1/15/2021 8:00:00 AM - 1/15/2024 9:00:00 AM, Dr. Morse describes Critical Race Theory and its intersection with public health policy regarding both specific topics such as Covid-19 care, heart failure, and race related calculation of kidney function, and general gaps in health equity in the United States. She examines White and institutional fragility as an impediment to scrutinizing structural racism, and encourages health professionals to address fundamental competencies by accepting that ecological and social components shape symptoms, diseases and related health outcomes.
Presenter
Michelle Morse, MD, MPH
Assistant Professor, Harvard Medical School
Robert Wood Johnson Foundation Health Policy Fellow
About our presenter:
Dr. Michelle Morse is an internal medicine and public health doctor at Brigham and Women’s Hospital (BWH) in the Division of Global Health Equity, and Assistant Professor at Harvard Medical School. She co-founded EqualHealth, an organization that builds critical consciousness and collective action globally towards achieving health equity. She was previously the deputy chief medical officer for Partners in Health (PIH) and now serves on the PIH board of directors.
Learning Outcome(s)
Participants will be able to describe anti-racism and historical examples in health policy, comment on current efforts to expand and scale anti-racism, and propose paths forward for anti-racist health policy remedies.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Michelle Morse, MD, MPH
Assistant Professor, Harvard Medical School
Robert Wood Johnson Foundation Health Policy Fellow
About our presenter:
Dr. Michelle Morse is an internal medicine and public health doctor at Brigham and Women’s Hospital (BWH) in the Division of Global Health Equity, and Assistant Professor at Harvard Medical School. She co-founded EqualHealth, an organization that builds critical consciousness and collective action globally towards achieving health equity. She was previously the deputy chief medical officer for Partners in Health (PIH) and now serves on the PIH board of directors.
Learning Outcome(s)
Participants will be able to describe anti-racism and historical examples in health policy, comment on current efforts to expand and scale anti-racism, and propose paths forward for anti-racist health policy remedies.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
